CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 102 enrolled
Drug / intervention
LIFT Mindfulnessbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04816708
NCT04816708N/ACompleted
CompareCT.gov

A Self-directed Mobile Mindfulness Intervention to Address Distress and Burnout in Frontline Healthcare Workers

Duke University·interventional·Posted Mar 25, 2021·Updated Feb 22, 2024

In Brief

A clinical study evaluating LIFT Mindfulness for Emotional Distress and 4 related conditions. Completed, enrolled 102 participants across 1 site.

Detailed Summary

This is a pilot randomized waitlist control trial assessing if the feasibility of using a mobile mindfulness app to treat emotional distress and burnout amongst nurses taking care of COVID-19 patients. This trial will help inform the study team if dissemination the intervention to a large number of nurses in a short time period is feasible, and if the intervention has evidence of a clinical impact.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEmotional Distress, Burnout, Professional, Stress, Job, Anxiety, Depressive Symptoms
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 25, 2021
Enrollment StartMay 19, 2021
Primary CompletionJan 30, 2022
Study CompletionFeb 4, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 5.3 years ago

Interventions

LIFT Mindfulnessbehavioral

Mindfulness is a type of mind-body therapy that promotes a practice of non-judgmental awareness that can alleviate distress by uncoupling emotional reactions and habitual behavior from unpleasant symptoms, thoughts, and emotions. LIFT is a mobile mindfulness app which can assess levels of emotional distress via survey, and subsequently offer mindfulness content that has previously been used in ICU patients, where it was shown to reduce symptoms of depression, anxiety, and PTSD.